Abstract
Microbes have been used for millenia in food and alcoholic fermentations; in recent years, microbes have undergone scientific scrutiny of their ability for preventive and therapeutic effects in humans. This work has led to the establishment of a new term, “probiotics.” Lactic acid bacteria (LAB) are normal microflora of the intestine of most animals. They play an important role in humans and other animals and act as an immunomodulator. LAB are helpful in disease treatment and prevention, as well as for improved digestion and absorption of nutrients. Probiotic microorganisms include LAB i.e., Lactobacillus acidophilus, L. bulgaricus, L. casei, L. plantarum, L. rhamnosus, etc. Use of these live bacteria to elicit an immune response or to carry a vaccine component is a new development in vaccine formulation. The advantages of live bacterial vaccines are their ability to mimic the natural infection, their intrinsic adjuvant properties, and that they can be administered orally. Components of pathogenic and nonpathogenic food-related microbes are currently being evaluated as candidates for oral vaccines.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Akira, S., Takeda, K. and Kaisho, T. (2001) Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2: 675–680.
Aldovini, A. and Young, R. A. (1991) Humoral and cell-mediated immune response to live recombinant BCG-HIV vaccines. Nature 351: 479–482.
Anderson, E. J. and Weber, S. G. (2004) Rotavirus infection in adults. Lancet Infect. Dis. 4(2): 91–99.
Benyacoub, J., Hopkins, S., Potts, A., Kelly, S., Kraehenbuhl, J. P., Curtiss, R. III, De Grandi, P. and Nardelli-Haefliger, D. (1999) The nature of the attenuation of Salmonella typhimurium strains expressing human papillomavirus type 16 virus-like particles determines the systemic and mucosal antibody responses in nasally immunized mice. Infect. Immun. 67: 3674–3679.
Bernet, M. F., Brassart, D., Neeser, J. R. and Servin, A. L. (1994).Lactobacillus acidophilus LA1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria. Gut 35: 483–489.
Blackman, M. J., Ling, I. T., Nicholls, S. C. and Holder, A. A. (1991) Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol. Biochem. Parasitol. 49: 29–33.
Casas, I. A. and Dobrogosz, W. J. (1997) Lactobacillus reuteri: overview of a new probiotic for humans and animals. Microecol. Ther. 26: 221–231.
Chukeatirote, E. (2003) Potential use of probiotics Songklanakarin. J. Sci. Technol. 25(2): 275–282.
Classen, E., Van Vinsen, R., Posko, M. and Boersma, W. A. U. (1995) New and safe “oral” live vaccines based on Lactobacillus. Adv. Exp. Med. Biol. 371B: 1553–1558.
Detme, A. and Glenting, J. (2006) Live bacterial vaccines – A review and identification of potential hazards. Microb. Cell Fact. 5: 23.
Dietrich, G., Griot-Wenk, M., Metcalfe, I. C., Lang, A. B. and Viret, J. F. (2003) Experience with registered mucosal vaccines. Vaccine 21: 678–683.
Donohue, D. C. and Salminen, S. (1996) Safety of probiotic bacteria. Asia Pac. J. Clin. Nutr. 5: 25–28.
Elmer, G. W. (2001) Probiotics: “living drugs.” Am. J. Health Syst. Pharm. 58: 1101–1109.
Fuller, R. (1989) Probiotics in man and animals. J. Appl. Bacteriol. 66: 365–378.
Fuller, R. (1991) Probiotics in human medicine. Gut 32: 439–442.
Goldin, B. R. Gorbach, S. L., Saxelin, M., Barakat, S., Gualtieri, L. and Salminen, S. (1992) Survival of Lactobacillus species (strain GG) in human gastrointestinal tract. Dig. Dis. Sci. 37: 121–128.
Gomboova, A., Deme, P. and Valent, M. (1986) Immunotherapeutic effect of the lactobacillus vaccine, Solco Trichovac, in trichomoniasis is not mediated by antibodies cross reacting with Trichomonas vaginalis. Genitourin. Med. 62: 107–110.
Gonzalez, S. N., Cardoza, R., Apella, M. C. and Oliver, G. (1995) Biotherapeutic role of fermented milk. Biotherapy 8: 129–134.
Goodwin, J. S. (1995) Decreased immunity and increased morbidity in the elderly. Nutr. Rev. 53:S41–S46.
Greene, J. D. and Klaenhammer, T. R. (1994) Factors involved in adherence of Lactobacilli to human Caco-2 cells. Appl. Environ. Microbiol. 60: 4487–4494.
Havenaar, R., Brink, B. T. and Huisin’t Veld, J. H. J. (1992) Selection of strains for probiotic use. In: Probiotics, the Scientific Basis. Fuller R., ed. Chapman and Hall, London. 209–224
Holder, A. A. and Freeman, R. R. (1981) Immunization against blood-stage rodent malaria using purified parasite antigens. Nature 294: 361–364.
Holzapfel, W. H., Haberer, P., Snel, J., Schillinger, U. and HuisIn’t Veld, J. H. (1998) Overview of gut flora and probiotics. Int. J. Food Microbiol. 41: 85–101.
Isolauri, E., Juntunen, M., Rautanen, T., Sillanaukee, P. and Koivula, T. (1991) A human Lactobacillus strain (Lactobacillus casei sp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 88: 90–97.
Jack, R. W., Tagg, J. R. and Ray, B. (1994) Bacteriocins of Grampositive bacteria. Microbiol. Rev. 59: 171–200.
Kajikawa, A. E., Satoh, R. J., Leer, S., Yamamoto, S. and Igimi, S. (2007) Intragastric immunization with recombinant Lactobacillus casei expressing flagellar antigen confers antibody-independent protective immunity against Salmonella enterica serovar Enteritidis. Vaccine 25: 3599–3605.
Ke-Qin, X., Yuka, H., Yoshihiko, T., Shizunobu, I., Yoshitsugu, K., Nao, J., Kenji, O., Akira, K., Mayumi, K., Kenji, H., Dennis, K. and Kenji, O. (2003) Immunogenicity and protective efficacy of orally administered recombinant Lactococcus lactis expressing surface-bound HIV Env. Blood 102: 223–229.
Khansari, D. N., Murgo, A. J. and Faith, A. E. (1990) Effects of stress on the immune system. Immunol. Today 11: 170–175.
Kirjavainen, P. E., Ouwehand, A. C., Isolauri, E. and Salminen, S. J. (1998) The ability of probiotic bacteria to bind to human intestinal mucus. FEMS Microbiol. Lett. 167: 185–189.
Klijn, N., Weerkamp, A. H. and de Vos, W. M. (1995) Genetic marking of Lactococcus lactis shows its survival in the human gastrointestinal tract. Appl. Environ. Microbiol. 61: 2771–2774.
Kochi, S. K., Killeen, K. P. and Ryan, U. S. (2003) Advances in the development of bacterial vector technology. Expert. Rev. Vaccines 74(2): 31–43.
Korik, L. M., Ljubimova, L. K. and Tovstolec, K. P. (1968) Immediate and remote results of treatment of trichomonosis in men with trichomonal vaccine. Vestn. Dermatol. Venerol. 42: 80–84.
Kotloff, K. L., Noriega, F., Losonsky, G. A., Sztein, M. B., Wasserman, S. S., Nataro, J. P. and Levine, M. M. (1996) Safety, immunogenicity, and transmissibility in humans of CVD 1203, a live oral Shigella flexneri 2a vaccine candidate attenuated by deletions in aroA and virG. Infect. Immun. 64: 4542–4548.
Kukreja, R. C., Kontos, M. C. and Hess, M. L. (1996) Free radicals and heat shock protein in the heart. Ann. NY Acad. Sci. 793: 108–122.
Lin, S. Y. and Chen, C. T. (2000) Reduction of cholesterol by Lactobacillus acidophilus in culture broth. J. Food Drug Anal. 8: 97–102.
Lin, S. Y., Ayres, J. W., Winkler, W. and Sandine, W. E. (1989) Lactobacillus effects on cholesterol: in vitro and in vivo results. J. Dairy Sci. 72: 2885–2899.
Lindberg, A. A. (1995) The history of live bacterial vaccines. Dev. Biol. Stand. 84: 211–219.
Lindberg, A. A. (1998) Vaccination against enteric pathogens: from science to vaccine trials. Curr. Opin. Microbiol. 1: 116–124.
Link-Amster, H., Rochat, F., Saudan, K., Mignot, O. and Aeschlimann, J. (1994) Modulation of a specific humoral immune response and changes in intestinal flora mediated through fermented milk. FEMS Immunol. Med. Microbiol. 10: 55–63.
Matsuzak, T. and Chin, J. (2000) Modulating immune response with probiotic bacteria. Immunol. Cell Biol. 78: 67–73.
Mattingly, J. and Waksman, B. (1978) Immunologic suppression after oral administration of antigen I Specific suppressor cells formed in rat Peyer’s patches after oral administration of sheep erythrocytes and their systemic migration. J. Immunol. 121: 1878–1883.
McGhee, J. R., Mestecky, J., Dertzbaugh, M. T., Eldridge, J. H., Hirasawa, M. and Kiyono, H. (1992) The mucosal immune system: from fundamental concepts to vaccine development. Vaccine 10: 75–88.
Mercenier, A., Muller-Alouf, H. and Grangette, C. (2000) Lactic acid bacteria as live vaccines. Curr. Issues Mol. Biol. 2: 17–25.
Metchnikoff, E. (1908) The prolongation of life. New York, NY: CP Putnam’s Sons. 151–183.
Miller, L. H., Roberts, T., Shahabuddin, M. and McCutchan, T. F. (1993) Analysis of sequence diversity in the Plasmodium falciparum merozoite surface protein-1 (MSP-1). Mol. Biochem. Parasitol. 59: 1–14
Morimoto, R. I. and Santoro, M. G. (1998) Stress-inducible responses and heat shock proteins: new pharmacologic targets for cytoprotection. Nat. Biotechnol. 16: 833–838.
Nardelli-Haefliger, D., Kraehenbuhl, J. P., Curtiss, R. III, Schodel, F., Potts, A., Kelly, S. and De Grandi, P. (1996) Oral and rectal immunization of adult female volunteers with a recombinant attenuated Salmonella typhi vaccine strain. Infect. Immun. 64: 5219–5224.
Netherwood, T., Gilbert, H. J., Parker, D. S. and O’Donnell, A. G. (1999) Probiotics shown to change bacterial community structure in the avian gastrointestinal tract. Appl. Environ. Microbiol. 65: 5134–5138.
Neutra, M. and Krahenbuhl, J. (1996) M cells as a Pathway for antigen uptake and processing. In: Essentials of Mucosal Immunology. Kagnoff M. and Kiyono H., eds. Academic, New York, NY. 2: 29–36.
Ouwehand, A. C., Kirjavainen, P. V., Gronlund, M. M., Isolauri, E. and Salminen, S. (1999) Adhesion of probiotic micro-organisms to intestinal mucus. Int. Dairy J 9: 623–630.
Pawelec, G., Adibzadeh, M., Pohla, H. and Schaudt, K. (1995) Immunosenescence: aging of the immune system. Immunol. Today 16: 420–422.
Perdigón, G. and Alvarez, S. (1992) Probiotics and the immune state. In: Probiotics. The Scientific Basis. Fuller R., ed. Chapman and Hall, London. 7: 145–180.
Phillips-Quagliata, J. and Lamm, M. (1988) Migration of lymphocytes in the mucosal immune system. In: Migration and Homing of Lymphoid Cells. Husband A., ed. CRC Press, Boca Raton, FL. 53–75.
Reid, G. (1999) The scientific basis for probiotic strains of Lactobacillus. Appl. Environ. Microbiol. 65: 3763–3766.
Reid, G. and Burton, J. (2002) Use of Lactobacillus to prevent infection by pathogenic bacteria. Microbes Infect. 4: 319–324.
Reid, G., Servin, A., Bruce, A. W. and Busscher, H. J. (1993) Adhesion of three Lactobacillus strains to human urinary and intestinal epithelial cells. Songklanakarin J. Sci. Technol. Microbios. 75: 57–65.
Salimen, S., Isolauri, E. and Salimen, E. (1996) Probiotics for stabilising the gut mucosal barrier: successful strains and future challenges. Antonie van Leeuwenhoek 70: 347–358.
Sarem-Damerdjii, L. O., Sarem, F., Marchal, L. and Nicolas, J. P. (1995) In vitro colonisation ability of human colon mucosa by exogenous Lactobacillus strains. FEMS Micorbiol. Lett. 131: 133–137.
Schnell, M. J., Foley, H. D., Siler, C. A., Mc Gettigan, J. P., Dietzachold, B. and Pomerantz, R. J. (2000) Recombinant rabies virus as potential live-viral vaccines for HIV-1. Proc. Natl. Acad. Sci. USA 97: 3544–3549.
Shornikova, A. V., Casas, A., Mykkanen, H., Salo, E. and Vesikari (1997) Bacteriotherpy with Lactobacillus reuteri in rotavirus gastroenteritis. Pediatr. Infect. Dis. J. 16: 1103–1107.
Singh, V., Singh, K., Amdekar, S., Singh, D. D., Tripathi, P., Sharma, G. L. and Yadav, H. (2008) Innate and specific gut-associated immunity and microbial interference. FEMS Immunol. Med. Microbiol. 55: 6–12.
Strobel, S. (1995) Oral tolerance. In: Mucosal Immunity and the Gut Epithelium: Interactions in Health and Disease. Dyn Nutr Res. Karger, Basel. 4: 65–75.
Tahri, K., Grill, J. P. and Schneider, F. (1996) Bifidobacteria strain behavior toward cholesterol: Coprecipitation with bile salts and assimilation. Curr. Microbiol. 33: 187–193.
Tatyana, O., Michal, S., Adriana, D., Klein, R., Natalie, A. and Babeth, R. (2000) A new method of long-term preventive cardioprotection using Lactobacillus. Am. J. Physiol. Heart Circ. Physiol. 278: 1717–1724.
Underdahl, H., Medina, A. and Doster, A. (1982) Effect of Streptococcus faecium C-68 in control of Escherichia coli induced diarrhea in gnotobiotic pigs. Am. J. Vet. Res. 43: 2227–2232.
Velazquez, F. R., Matson, D. O., Calva, J. J., Guerrero, S. L., Morrow, A. L., Carter-Campbell, S., Glass, R. I., Estes, M. K., Pickering, L. K. and Ruiz-Palacios. (1996) Rotavirus infections in infants as protection against subsequent infections. N. Eng. J. Med. 335(14): 1022–1028.
Weissman, D., Ni, H., Scales, D., Dude, A., Capodici, J., Mcgibney, K. Abdool., Isaacs, S., Cannon, G. and Kariko, K. (2000) HIV gag mRNA transfection of dendritic cells (DC) delivers encoded antigen to MHC class I and II molecules, causes DC maturation, and induces a potent human in vitro primary immune response. J. Immunol. 165: 4710–4717.
Woodward B (1998) Protein, calories and immune defenses. Nutr. Rev. 56: S84–S92.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Singh, V., Amdekar, S., Yadav, H., Mishra, N.N., Jain, S. (2011). Future Application of Probiotics: A Boon from Dairy Biology. In: Ahmad, I., Ahmad, F., Pichtel, J. (eds) Microbes and Microbial Technology. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7931-5_4
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7931-5_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7930-8
Online ISBN: 978-1-4419-7931-5
eBook Packages: Earth and Environmental ScienceEarth and Environmental Science (R0)